Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Voyageur Pharmaceuticals Ltd. (V:VM)

Business Focus: Pharmaceuticals

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for VM within the last 6 months
See all filings within the past 6 months

Company News

Apr 20, 2021 06:04 ET
Recent Decision from DC Circuit Court Likely to Result in Less Cost and Faster Approvals for Voyageur Barium Products - Voyageur Hires Team of Experts to Support Product Roll-Out
Calgary, Alberta – TheNewswire - April 20, 2021 – Voyageur Pharmaceuticals Ltd. (TSX.V:VM) USA (OTC:VYYRF) (the “Company” or “Voyageur”), is pleased to announce that the D.C. Circuit Court of Appeals
Read full article
Apr 13, 2021 07:04 ET
Voyageur Pharmaceuticals Ltd. Announces up to $1,725,000 Private Placement Financing
Calgary, Alberta – TheNewswire - April 13th 2021 – Voyageur Pharmaceuticals Ltd. (TSXV:VM) USA (OTC:VYYRF) (the “Company” or “Voyageur”), is pleased to announce a proposed non-brokered private placement financing of up to 11,500,000 units, for gross proceeds of up to $1,725,000 (the "Offering").  Under the Offering, the Company expects to raise up to $1,500,000, but has approved up to $1,725,000 to give the Company an option to increase the Offering by up to 15% to cover over-allocations, if any.  Pricing is as follows: A "Common Unit" priced at $0.15 where each Common Unit is comprised of on
Read full article
See more news stories

Valuation Ratios

Price to Sales - TTM
Price to Book - most recent quarter
Price to Cash Flow per share - TTM
Price to Free Cash Flow per share - TTM
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Apr 15, 2021562,636346,900
Mar 31, 2021215,736-173,409
Mar 15, 2021389,145300,078
See Short Report

Business Summary

Sector:  Healthcare Industry:  Pharmaceuticals

Voyageur Pharmaceuticals Ltd., formerly Voyageur Minerals Ltd., is an exploration stage pharmaceutical company. The Company is focused on manufacturing mineral based pharmaceutical products. The Company is engaged in the acquisition, exploration and evaluation of pharmaceutical mineral resource properties. It has interests in five mineral properties located in the province of British Colombia, Canada and the state of Utah, United States of America.

See business summary



Search (past week) for $VM.CA VM.V